Absence of progression correctly identified by subsequent MRI in nearly 95, 90, 70 percent of men with grade group 0, 1, 2, respectively
Read More »All-Cause Mortality Higher With Sleep Deprivation in Seniors With Epilepsy
After adjustment for demographic and health variables, hazard ratio was 1.94 for individuals with epilepsy and sleep deprivation
Read More »Doctors Perform First-Ever Human Bladder Transplant in U.S.
By I. Edwards HealthDay ReporterMONDAY, May 19, 2025 (HealthDay News) — Doctors in Southern California have performed the first human bladder transplant, offering new hope to people with serious bladder problems.The surgery was done earlier this month by two doctors from the University of California, Los Angeles (UCLA) and the …
Read More »FDA Gives Full OK to Novavax COVID Shot for High-Risk Groups
By I. Edwards HealthDay ReporterMONDAY, May 19, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax’s COVID-19 vaccine, but only for certain people.The vaccine is now approved for adults ages 65 and older, or for people ages 12 to 64 who have …
Read More »Calorie Restrictions, Low-Fat Diets May Reduce Depressive Symptoms
Small effects on depressive symptoms seen with calorie restriction and low-fat diets for adults with elevated cardiometabolic risk
Read More »Nicotine Pouch Use in Teens Linked to Lower Risk for Continued Vaping
Use of nicotine pouches also inversely associated with past 30-day vaping frequency at follow-up
Read More »Republican Medicaid Cuts Could Cause Rural Hospital Closures, CEOs Warn HealthDay TV
By Dennis Thompson HealthDay ReporterFRIDAY, May 16, 2025 (HealthDay News) — Proposed cuts to Medicaid could be devastating to America’s rural hospitals, health care CEOs are warning in interviews with HealthDay.House Republicans have proposed an $880 billion reduction in Medicaid funding. Combined with other health care cuts, the package could …
Read More »Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills
By I. Edwards HealthDay ReporterFRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.The deal could be worth up to $2.2 billion for Septerna. This includes more than …
Read More »FDA Gives Marketing Nod to Blood Test for Diagnosing Alzheimer Disease
Noninvasive diagnostic test measures two proteins, pTau217 and β-amyloid 1-42, found in human plasma
Read More »Greater Sedentary Time Associated With Higher Risk for Alzheimer Disease
Association with Alzheimer disease seen in cross-sectional and longitudinal models
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.